Displaying drugs 2376 - 2400 of 2778 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Ceftobiprole | 534.57 C20H22N8O6S2 |  | A broad spectrum 5th-generation cephalosporin antibacterial indicated for certain kinds of pneumonia, bacteremia, and skin and skin structure infections, including those caused by MRSA. | Anti-Bacterial Agents |
| Piperaquine | 535.52 C29H32Cl2N6 |  | For the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg [FDA Label]. Used in combination with DB11638. | Anti-Infective Agents / Antimalarials / Antiparasitic Agents / Antiparasitic Products, Insecticides and Repellents / Antiprotozoals / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (weak) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP2E1 Inducers / Cytochrome P-450 CYP2E1 Inducers (strength unknown) / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Heterocyclic Compounds, Fused-Ring |
| Lycopene | 536.888 C40H56 |  | An ingredient found in a variety of supplements and vitamins. | Anti-Inflammatory Agents / Anticarcinogenic Agents / Antioxidants / Carotenoids / Radiation-Protective Agents |
| Beta carotene | 536.888 C40H56 |  | A vitamin A precursor found in various nutritional supplements and health products. | Protectives Against UV-Radiation for Systemic Use |
| Ambenonium | 537.565 C28H42Cl2N4O2 |  | A cholinesterase inhibitor that targets both muscarinic and nicotinic receptors indicated for the treatment of myasthenia gravis. | Parasympathomimetics |
| Fluticasone furoate | 538.576 C27H29F3O6S |  | An inhaled corticosteroid that can be used as maintenance treatment of asthma and/or chronic obstructive pulmonary disease (COPD) depending on the product. Also available as a nasal spray to manage symptoms of allergic rhinitis. | Glucocorticoids |
| Mezlocillin | 539.582 C21H25N5O8S2 |  | Used to treat serious gram–negative infections of the lungs, urinary tract, and skin. | Penicillins With Extended Spectrum |
| Nintedanib | 539.6248 C31H33N5O4 |  | A triple angiokinase inhibitor indicated for the treatment of idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and in combination with docetaxel for non-small cell lung cancer. | Protein Kinase Inhibitors |
| Choline magnesium trisalicylate | 539.814 C26H29MgNO10 |  | Choline magnesium trisalicylate is used to reduce pain and inflammation caused by conditions such as arthritis. This medication is also used to treat fever in adults. | Agents that produce hypertension |
| Encorafenib | 540.01 C22H27ClFN7O4S |  | A kinase inhibitor used to treat unresectable or metastatic melanoma with specific mutations. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors |
| Romidepsin | 540.69 C24H36N4O6S2 |  | A histone deacetylase (HDAC) inhibitor used to treat cutaneous T-cell lymphoma. | Histone deacetylase (HDAC) inhibitors |
| Ciclesonide | 540.697 C32H44O7 |  | A glucocorticoid used in the symptomatic relief of nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents. | Glucocorticoids |
| Cefonicid | 542.566 C18H18N6O8S3 |  | For the treatment of bacterial infections caused by susceptible microorganisms. | Anti-Bacterial Agents / Second-Generation Cephalosporins |
| Manganese citrate | 543.012 C12H10Mn3O14 |  | Not Annotated | Not Annotated |
| Indium In-111 oxyquinoline | 543.364 C27H18InN3O3 |  | A radiopharmaceutical diagnostic agent used for radiolabeling autologous leukocytes as an adjunct in the detection of inflammatory processes to which leukocytes migrate. | Radioactive Diagnostic Agent |
| Epirubicin | 543.5193 C27H29NO11 |  | An anthracycline topoisomerase II inhibitor used as an adjuvant to treating axillary node metastases in patients who have undergone surgical resection of primary breast cancer. | Anthracyclines and Related Substances |
| Doxorubicin | 543.5193 C27H29NO11 |  | A medication used to treat various cancers, including AIDS-associated Kaposi's Sarcoma and metastatic cancers. | Anthracyclines and Related Substances |
| Omacetaxine mepesuccinate | 545.6213 C29H39NO9 |  | A cephalotaxine used in the treatment of Chronic Myeloid Leukemia (CML) that is intolerant to or resistant to two or more tyrosine kinase inhibitors. | Antineoplastic Agents |
| Isosulfan blue | 545.69 C27H33N2O6S2 |  | A visual lymphatic imaging agent used during lymphography as an adjunct. | Coloring Agents |
| Aprocitentan | 546.19 C16H14Br2N6O4S |  | An endothelin receptor antagonist used for the treatment of uncontrolled hypertension in patients inadequately controlled on other treatments. | Amides / BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / BSEP/ABCB11 Inhibitors / Cytochrome P-450 CYP2C18 Inhibitors / Cytochrome P-450 CYP2C18 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Endothelin Receptor Antagonists / P-glycoprotein substrates / Sulfones / Sulfur Compounds / UGT1A1 Inhibitors / UGT1A1 Substrates / UGT2B7 Inhibitors / UGT2B7 substrates |
| Ceftazidime | 546.576 C22H22N6O7S2 |  | An injected broad-spectrum third-generation cephalosporin beta-lactam antibiotic used to treat or prevent a variety of bacterial infections, including pneumonia, gynecological infections, bone and joint infections, and septicemia, among others. | beta Lactam Antibiotics |
| Gadopentetic acid | 547.58 C14H20GdN3O10 |  | A gadolinium compound used as a contrast agent in MRIs. | Paramagnetic Contrast Media |
| Darunavir | 547.664 C27H37N3O7S |  | A HIV protease inhibitor used in the treatment of human immunodeficiency virus (HIV) infection in patients with history of prior antiretroviral therapies. | Sulfonamides |
| Edoxaban | 548.06 C24H30ClN7O4S |  | A novel oral anticoagulant used for reducing the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF). | Direct factor Xa inhibitors / Factor Xa Inhibitors |
| Ubrogepant | 549.554 C29H26F3N5O3 |  | An oral CGRP antagonist used in the acute treatment of migraine with or without aura. | Calcitonin Gene-Related Peptide (CGRP) Antagonists |
Displaying drugs 2376 - 2400 of 2778 in total